Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I haven't seen any date on the sales campaign actually beginning except Q1. I assume they will have a PR on kickoff day. Anyone have any better info? Obviously it should be this month to make Q1.
Monster day today.
Short interest upto 11,464,405 6.6 days to cover As of 2/15
The biggest hurdle is the investor worry about opioids. However I think the restrictions on hospital/medical facility usage and the fact that it won't be prescribed outside of the medical facilities will overcome those fears. We do need their sales team to effectively present the product and get some reportable sales quickly. I like their strategy of going after the best candidates for usage of the product and the gradual rampup.
Indeed. A good day. This is going to be a monster once sales go through. Institutions are watching this. Should move rapidly once it gets news and above $5, at least that's what logic would predict but this is the market...
ACRX +.21 to C3.37 nice day today with steady support and stock climbing to high of the day. Decent volume so I think institutional investors are positive about the approach that AcelRX is taking with their sales campaign. I think hospitals will respond to the efficiency aspect of self contained dosing versus waiting for personnel to get an IV going.
Thank you for the information....
I will definitely pass it along!
Hornet, have your friend try this company maybe they can help..my wife work there as an MD consultant, they are growing in different states.
https://idealoption.net/
That is terrible. There definitely need to be safeguards in place. But there is still a fundamental need for painkillers.
Yes addiction and dependency is a very bad problem with all pain killers. That i know first hand with a close friend of mine. He is on methedone pretty much for life almost Oded on oxycotten and fentenal both.
Indeed. AFAICT the main objection here is that the product is *too* effective and thus has the potential to be addictive. Isn't that the case with virtually any effective pain killer?
I think it shows that they know they have a good product.
I'm just going off what E*Trade shows.
What I love is the steady insider buying. With a few exceptions (Sept/Oct and January) the management is accumulating their own stock month after month like nobody's business.
No problem Are you in or just watching?
Thanks for your response.
They are indeed opiods. But lets be honest, opiods ARE NEEDED, there is a huge shortage. The idea here is in single dosage... small count per carton in sales and shipments.
Interesting read about this poppin stock
https://www.google.com/url?sa=i&source=web&cd=&ved=2ahUKEwishaeJy8vgAhULXa0KHYIEBY8QzPwBegQIARAC&url=https%3A%2F%2Fnysenasdaqnews.com%2F2019%2F02%2F20%2Fhot-stock-that-must-be-in-your-portfolio-acelrx-pharmaceuticals-inc-nasdaq-acrx%2F&psig=AOvVaw1Z2MTFVk-YM3TgWpPC4PJp&ust=1550795904469624
Thanks for the reply
3.60 would be the shiznit. Poppin up close for sure.
Doing some DD on this one, question : are these non- opioid pain meds ?
Thanks
Next resistance to get through $3.60-$3.8 area hope it can do it!
Glad i hit some at premarket and more at opening bell. Great news moving up. Ace in the hole!
It should hold, a bit of consolidation and profit taking, but at these levels that is silly. The trend is up. GL to you as well.
Very nice to see so much green here. Best of luck to all.
Thanks again chart is looking good.
Hey...I don't have subscription so I can't reply in private. Just want to say I saw your private email...You're welcome although I got lucky on timing...no insider knowledge...lol
Close near the 200 day today nice. Next resistance $3.60
Oh wow 3x times cheaper than morhphine. That's interesting!
Independent Research - PT $10.65
https://medium.com/@jscharmer/acelrx-pharmaceuticals-acrx-price-target-of-10-65-75788d15228f
Stockboy, i totally agree. I also laugh at those that truly believe in charts and timings. All this complication has been created simple to make the average person think they need to go to school to learn how to trade.
In this time and age its very very very simple. A person should learn about a company, see if it has a product that can appeal and be sold to the end consumer.
If yes, get in early...buy low and don't fall in love or get attached. Sell for a profit
I can give so many suggestions and methods to make money on the market, but one thing for sure don't short. Its a dangerous game.
IMHO and in what I truly believe is ACRX has a product that is going to meet an important need, local and international, at the hospitals and most importantly in the battlefield. When hospitals realize the savings and quick action they can treat a patient, its going to be their favorite Pain medication to provide quick pain relief to their patients.
Personally i am long in ACRX and will never sell all my shares as i know in 2 to 3 years this will be above and stable over $50+.
Cheers mate.
I would take $16-18 all day long! Point taken on analysts.
All the price targets are 8-10 in the next 12 months. Analysts are so full of it. I was In One stock they adjusted the price target weekly as the stock was rising above their target. Lol they finally raised it to $35 when it was 12 they’d 15 when it was $16 they raised it to 18 then it hits $18 they raised it to $20 when it hit $23 they finally got tired looking like idiots. Raised it to $35 then it fell back to 12 now it’s stuck in a range between 16-18.
Thank you so much for that great read!
www.fairfieldcurrent.com/news/2019/02/09/blackrock-inc-has-3-03-million-position-in-acelrx-pharmaceuticals-inc-acrx.html
New to acrx grabing up some shares tuesday. Hopeing to see a dip to previous support around the 2.60 ranges. Looks like great news nice upward trending pattern. Lots of shares owned by insiders which i take as a strong sign of things to come.
Is the black rock investing documented. In like writing. Can you post that info please would like to read it.
I'm ramping up my shares and getting ready for the earnings call.
I think with them starting the shipment of products. They'll be smashing the earnings expectations.
The stock price will ramp up towards the $10.00 per share before the earnings call.
This stock will hit $10.00 minimum. When a person reads carefully the Q&A and see the information the company provided and sees their reasoning behind the product, one will come to realize how huge the solution this company is bringing to the market.
I have seen this type of stock /company before. It may just surprise everyone.
We may not be able to catch it as it goes up.
My gut feeling tells me we may see jumps in the $ 5.00 per day. And it could spike as high as $50.00.
Like you said, the best thing to do it just wait.
Glta.
Yeah I think a lot of ppl wrote this off when it dropped under $3. When Black Rock added $3M though, that's a good sign. Just waiting this one out. Patience. Long term gains are good.
Very nice strong trading day on Friday. Agree with adding any dip on this stock is a gift. Many will jump in with us once we see any positive updates from the company about sales and shipping of goods.
I thought about posting a few times, got distracted. Looks good for the move up towards $7. News of the first shipment will be nice. Thx for the chart analysis, I added yesterday morning, will add again at the dip. Thanks!
Well the bollinger band volatility squeeze breakout occurred right on cue. It might test the breakout and fill the gap don’t panic and sell. If That’s does occurs it’s your 2nd chance to add more. 2.66 area is the buy zone if it does.
Board is quiet today for a nice up day.
Followers
|
94
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1456
|
Created
|
02/13/11
|
Type
|
Free
|
Moderators |
Market Cap: $108 Million
Cash: $72 Million
Price: $2.40
Shares Out: 45.3 Million
Upcoming Major Milestones
Zalviso Phase 3 Results in July 2017
DSUVIA PDUFA Date October 12, 2017
Zalsviso NDA Resubmission in Q4 2017
DSUVIA CHMP Opinion in 1H 2018 (EU Approval )
Presentation June 2017
http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NjczNjExfENoaWxkSUQ9MzgxNTY1fFR5cGU9MQ==&t=1
Jefferies Sees Strong Upside in AcelRx Pharmaceuticals’ Shares and Set a $7 Price Target
https://finance.yahoo.com/news/jefferies-sees-strong-upside-acelrx-145225845.html
Biotech Catalyst Play: AcelRx Pharmaceuticals Inc (NASDAQ:ACRX)...
https://insiderfinancial.com/biotech-catalyst-play-acelrx-pharmaceuticals-inc-nasdaqacrx
While Zalviso is our near-term catalyst, the DSUVIA decision probably holds more weight from a valuation perspective. Why? Because peak sales for this one are estimated at a little over $1.1 billion in the US alone. If FDA gives a green light for commercialization to the asset, therefore, the company could have a blockbuster drug on its hands. Combine that with the close to $400 million in revenues potential from Zalviso, and AcelRx could very justifiably become a multibillion-dollar biotech company before the end of the decade.
https://finviz.com/quote.ashx?t=acrx&ty=c&ta=1&p=d
Shs Outstand | 119.10M |
Shs Float | 116.83M |
Short Float | 13.47% |
Insider Own | 2.00% |
Inst Own | 34.80% |
Inst Trans | 43.60% |
Inst Trans | 43.60% |
ROE | 66.50% |
ROI | 120.80% |
Employees | 54 |
Forward P/E | 16.13 |
Recom | 1.70 |
52W Range | 1.01 - 2.94 |
minor resistance $1.70 [-chart]finviz.com/chart.ashx?t=acrx&ty=c&ta=1&p=d&s=l[/chart]
02-07-2021
DISCLAIMER: ONLY FOR MICK
https://investorshub.advfn.com/boards/profilea.aspx?user=1012
*The Board Monitor and herewithin , are not licensed brokers and assume NO responsibility for actions,
investments,decisions, or messages posted on this forum.
CONTENT ON THIS FORUM SHOULD NOT BE CONSIDERED ADVISORY NOR SOLICITATION
AUTHORS MAY HAVE BUYS OR SELLS WITH THE COMPANIES MENTIONED IN TRADING POSTERS SHOULD DUE DILIGENT BUYING OR SELLING.
ALL POSTING SHOULD BE CONSIDERED FOR INFORMATION ONLY. WE DO NOT RECOMMEND ANYONE BUY OR SELL ANY SECURITIES POSTED HEREWITHIN.
ANY trade entered into risks the possibility of losing the funds invested.
• There are no guarantees when buying or selling any security.Any
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads